AF 399 is a CCR4 antagonist. it reverses the tumor promoting environment.
Uses
HTS13517 is a DPP4 inhibitor, with an IC50 of 10.73 μM[1].
IC 50
DPP-4: 10.73 μM (IC50)
References
[1] Sharat Chandra, et al. SVMDLF: A novel R-based Web application for prediction of dipeptidyl peptidase 4 inhibitors. Chem Biol Drug Des. 2017 Dec;90(6):1173-1183. DOI:10.1111/cbdd.13037